Pathophysiology and Management of Self-Poisoning with Beta-Blockers

References

• Henry JA, Cassidy SL. Membrane stabilizing activity: a major cause of fatal poisoning. Lancet 1986; 1: 1414–1417
   PubMed Web of Science ®Google Scholar
• Ellenhorn MJ, Barceloux DG. Class II drugs: Beta-blockers. Medical Toxicology. Diagnosis and Treatment of Human Poisoning, MJ Ellenhorn, DG Barceloux. Elsevier, New York 1988; 187–194
   Google Scholar
• Bismuth C, Baud FJ, Muszynski J. Intoxication aiguë par les bétabloquants (80 cas). Conc Med 1989; 111: 1270–1272
   Google Scholar
• Boakes AJ, Boeree BH. Suicidal attempts with beta-adrenoceptor blocking agents. Br Med J 1973; 4: 675
   PubMed Web of Science ®Google Scholar
• Prichard BN, Battersby LA, Cruickshank JM. Overdosage with beta-adrenergic blocking agents. Adverse Drug React Acute Poisoning Rev 1984; 3: 91–111
   PubMedGoogle Scholar
• Elkharrat D, Bismuth C. Acute intoxication by beta-blocking agents: no mortality in 40 cases. Int J Clin Pharmacol Res 1982; 3: 207–210
   Google Scholar
• Kulling P, Eleborg L, Persson H. Beta-adrenoceptor blocker intoxication. Epidemiological data. Prenalterol as an alternative in the treatment of cardiac dysfunction. Hum Toxicol 1983; 2: 175–181
   PubMedGoogle Scholar
• Ellenhorn MJ, Barceloux DG. Beta-blocker. Medical Toxicology. Diagnosis and Treatment of Human Poisoning, MJ Ellenhorn, DG Barceloux. Elsevier, New York 1988; 187–194
   Google Scholar
• Chen TW, Huang TP, Yang WC, Hong CY. Propranolol intoxication: three cases' experiences. Vet Hum Toxicol 1985; 27: 528–530
   PubMedGoogle Scholar
• Langemeijer JJ, de Wildt DJ, de Groot G, Sangster B. Centrally induced respiratory arrest: a main cause of death in beta-adrenoceptor antagonist intoxication. Hum Toxicol 1986; 5: 65
   PubMedGoogle Scholar
• Love JN, Tandy TK. Beta-adrenoceptor antagonist toxicity: a survey of glucagon availability. Ann Emerg Med 1993; 22: 267–268
   PubMed Web of Science ®Google Scholar
• Weinstein RS. Recognition and management of poisoning with beta-adrenergic blocking agents. Ann Emerg Med 1984; 13: 1123–1131
   PubMed Web of Science ®Google Scholar
• Gibson DG. Pharmacodynamic properties of beta-adrenergic receptor blocking drugs in man. Drugs 1974; 7: 8–38
   PubMed Web of Science ®Google Scholar
• Hoffman BB, Lefkowitz RJ. Adrenergic receptor antagonist. Goodman and Gilman's The Pharmacological Basis of Therapeutics, 8th Ed., AG Gilman, TW Rail, AS Niew, P Taylor. Pergamon Press, New York 1990; 229–243
   Google Scholar
• Prichard B NC. Beta-adrenergic receptor blockade in hypertension, past, present and future. Br J Clin Pharmacol 1978; 5: 379–399
   PubMed Web of Science ®Google Scholar
• Lewis RV, McDevitt DG. Adverse reactions and interactions with beta-adrenoceptor blocking drugs. Med Toxicol 1986; 1: 343–361
   PubMedGoogle Scholar
• Coltart DJ, Shand DG. Plasma propranolol levels in the quantitative assessment of beta-adrenergic blockade in man. Br Med J 1970; 3: 731–734
   PubMed Web of Science ®Google Scholar
• Khan A, Muscat-Baron JM. Fatal oxprenolol poisoning. Br Med J 1977; 1: 552
   PubMed Web of Science ®Google Scholar
• Berdeaux A, Giudicelli JF. Plasma levels and pharmacodynamic activity of beta-adrenergic inhibitors. Therapie 1985; 40: 383–386
   PubMedGoogle Scholar
• Mylecharane EJ, Raper C. Further studies on the neuron blocking activity of some beta-adrenoceptor antagonists and guanethidine. J Pharm Pharmacol 1976; 23: 213–220
   Google Scholar
• Shand DG, Nuckolls EM, Oates JA. Plasma propranolol levels in adults. Clin Pharmacol Ther 1970; 11: 112–120
   PubMed Web of Science ®Google Scholar
• Hong CY, Yang WC, Chiang BN. Importance of membrane stabilizing effect in massive overdose of propranolol: plasma level study in a fatal case. Hum Toxicol 1983; 3: 511–517
   Google Scholar
• Frishman W, Jacob H, Eisenberg E, Rigner H. Clinical pharmacology of the new beta-adrenergic blocking agents. Part 8. Self-poisoning with beta-adrenoceptor blocking agents. Recognition and management. Am Heart J 1979; 98: 798–811
   PubMed Web of Science ®Google Scholar
• de Wildt D, Sangster B, Langemeijer J, de Groot G. Different toxicological profiles for various beta-blocking agents on cardiac function in isolated rat hearts. J Toxicol Clin Toxicol 1984; 22: 115–132
   PubMed Web of Science ®Google Scholar
• Moins N, Renoux M, Boucher M, Gachon P. Paradoxal pharmacologic effects observed with beta-blocker agents on cardiac cells in culture. In Vitro Cell Dev Biol 1991; 27A: 147–150
   PubMedGoogle Scholar
• Rokutanda M, Araki S, Sakanashi M. A pharmacological investigation on a possible calcium antagonistic action of propranolol. Arch Int Pharmacodyn Ther 1983; 262: 99–108
   PubMedGoogle Scholar
• Freslon JL. Couplage excitation-contraction des cellules musculaires: mécanismes et modulation pharmacologique. Pharmacologie Moléculaire, Y Landry, JP Gies. MEDSI/McGraw-Hill, Paris 1990; 265–294
   Google Scholar
• Levitan IB. Modulation of ion channels in neurons and other cells. Ann Rev Neurosci 1988; 11: 119–136
   PubMed Web of Science ®Google Scholar
• Kamm KE, Stull JT. Activation of smooth muscle contraction: relation between myosin phosphorylation and stiffness. Science 1986; 232: 80–82
   PubMed Web of Science ®Google Scholar
• Whitsitt LS, Lucchesi BR. Effects of beta-receptor blockade and glucagon on the atrioventricular transmission system in the dog. Circ Res 1968; 23: 585–595
   PubMed Web of Science ®Google Scholar
• Adelstein RS, Eisenberg E. Regulation and kinetics of the actin-myosin-ATP interaction. Annu Rev Biochem 1980; 49: 921–956
   PubMed Web of Science ®Google Scholar
• Kosinski EJ, Malindzak GS. Glucagon and isoproterenol in reversing propranolol toxicity. Arch Intern Med 1973; 132: 840–843
   PubMed Web of Science ®Google Scholar
• Femmer K, Poppe H, Schwela H, Oltmanns G, Fiekring H. Intoxicationen mit beta-receptoren blockern. Dt Gesundh Wesen 1983; 38: 259–263
   Google Scholar
• Love JN, Leasure JA, Mundt DJ, Janz TG. A comparison of amrinone and glucagon therapy for cardiovascular depression associated with propranolol toxicity in a canine model. J Toxicol Clin Toxicol 1992; 30: 399–412
   PubMed Web of Science ®Google Scholar
• Strubelt O. Evaluation of antidotes against the acute cardiovascular toxicity of propranolol. Toxicology 1984; 31: 261–270
   PubMed Web of Science ®Google Scholar
• Langemeijer J JM, de Wildt DJ, de Groot G. Respiratory arrest as main determinant of toxicity due to overdose with different beta-blockers in rats. Acta Pharmacol Toxicol 1985; 57: 352–356
   PubMedGoogle Scholar
• Emorine LJ, Marullo S, Briend-Sutren MM, et al. Molecular characterization of the human beta 3-adrenergic receptor. Science 1989; 245: 1118–1121
   PubMed Web of Science ®Google Scholar
• Starke K. Regulation of noradrenaline release by presynaptic receptor systems. Rev Physiol Biochem Pharmacol 1977; 77: 1–124
   PubMed Web of Science ®Google Scholar
• Best JD, Halter JB. Blood pressure and norepinephrine spillover during propranolol infusion in humans. Am J Physiol 1985; 248: R400–R406
   PubMed Web of Science ®Google Scholar
• Meyer PH. Les récepteurs présynaptiques, “modulateurs” de l'activité neuronale sympathique. Nouv Press Med 1979; 8: 1417–1420
   PubMedGoogle Scholar
• Hesse B, Pedersen JT. Hypoglycemia after propranolol in children. Acta Med Scand 1973; 193: 551–552
   PubMed Web of Science ®Google Scholar
• Rosa RM, Silva P, Young JB, et al. Adrenergic modulation of extrarenal potassium disposal. N Eng J Med 1980; 302: 431–434
   PubMed Web of Science ®Google Scholar
• Halloran TJ, Phillips CE. Propranolol intoxication, a severe case responding to norepinephrine therapy. Arch Intern Med 1981; 141: 810–811
   PubMed Web of Science ®Google Scholar
• Lane AS, Woodward AC, Goldman MR. Massive propranolol overdose poorly responsive to pharmacologic therapy: Use of the intra-aortic balloon pump. Ann Emerg Med 1987; 16: 1381–1383
   PubMed Web of Science ®Google Scholar
• Chollet A, Bismuth C, Gaultier PJ. Intoxications aiguës par les bêta-bloquants A propos de 20 cas. Bull Med Legal 1979; 283–289
   Google Scholar
• Agura ED, Wexler LF, Witzhurg RA. Massive propranolol overdose. Successful treatment with high dose isoproterenol and glucagon. Am J Med 1986; 180: 755–757
   Google Scholar
• Langemeijer J, de Wildt D, de Groot G, Sangster B. Calcium interferes with the cardiodepressive effects of beta-blocker overdose in isolated rats. J Toxicol Clin Toxicol 1986; 24: 111–133
   PubMed Web of Science ®Google Scholar
• Sangster B, de Wildt D, van Dijk A. A case of acebutolol intoxication. J Toxicol Clin Toxicol 1983; 20: 69–77
   PubMed Web of Science ®Google Scholar
• Moller B HJ. Massive intoxication with metoprolol. Br Med J 1976; 1: 222
   PubMed Web of Science ®Google Scholar
• Illingworth RN. Glucagon for beta-blocker poisoning. Practitioner 1979; 223: 683–685
   PubMedGoogle Scholar
• Peet M, Yates RA. Beta-blockers in the treatment of neurological and psychiatric disorders. J Clin Hosp Pharm 1981; 6: 151–171
   Google Scholar
• Richards DA, Prichard B NC. Self-poisoning with beta-blockers. Br Med J 1978; 1: 1623–1624
   PubMed Web of Science ®Google Scholar
• Buiumsohn A, Eisenberg ES, Jacob H, et al. Seizures and intraventricular conduction defect in propranolol poisoning. Ann Intern Med 1979; 91: 860–862
   PubMed Web of Science ®Google Scholar
• Warwick GL, Boulton-Jones JM. Recurrent cardiovascular collapse due to surreptitious ingestion of propranolol. Br Med J 1989; 298: 294–295
   PubMed Web of Science ®Google Scholar
• Montagna M, Groppi A. Fatal sotalol poisoning. Arch Toxicol 1980; 43: 221–226
   PubMed Web of Science ®Google Scholar
• Stajic M, Granger RH, Beyer JC. Fatal metoprolol overdose. J Anal Toxicol 1984; 8: 228–230
   PubMed Web of Science ®Google Scholar
• Krapf R, Gertsch M. Torsade de pointes induced by sotalol despite therapeutic plasma sotalol concentrations. Br Med J Clin Res Ed 1985; 290: 1784–1785
   PubMed Web of Science ®Google Scholar
• Neuvonen PJ, Elonen E, Vuorenmaa T, Laakson M. Prolonged Q-T interval and severe tachyarrhythmias, common features of sotalol intoxication. Eur J Clin Pharmacol 1981; 20: 85–89
   PubMed Web of Science ®Google Scholar
• Tynan RF, Fisher MM, Ibels LS. Self-poisoning with propranolol. Med J Aust 1981; 24: 82–83
   Google Scholar
• Ashouri OS. Metoprolol induced hyperkalemia in a diabetic with advanced renal failure. Arch Intern Med 1985; 145: 578
   PubMed Web of Science ®Google Scholar
• Freestone S, Thomas HM, Bhamra RK, Dyson EH. Severe atenolol poisoning: Treatment with prenalterol. Hum Toxicol 1986; 5: 343–345
   PubMedGoogle Scholar
• Ward DE, Jones B. Glucagon and beta-blocker toxicity. Br Med J 1976; 2: 151
   PubMed Web of Science ®Google Scholar
• Levey GS, Epstein SE. Activation of adenylate cyclase by glucagon in cat and human heart. Circ Res 1969; 24: 151–156
   PubMed Web of Science ®Google Scholar
• Smith RC, Wilkinson J, Hull RL. Glucagon for propranolol overdose. JAMA 1985; 254: 2412
   PubMed Web of Science ®Google Scholar
• Parmley WW. The role of glucagon in cardiac therapy. N Engl J Med 1971; 285: 801–802
   PubMed Web of Science ®Google Scholar
• Jacobsen D, Helgeland A, Koss A. Treatment of beta-blocker poisoning. Lancet 1980; 1: 1031–1032
   PubMedGoogle Scholar
• Goldfrank LR, Lewin NA, Howland MA, Kirstein RH, Hartnett L. Digitalis, beta blockers, calcium channel blockers, and clonidine. Goldfrank's Toxicologic Emergencies, 4th ed., LR Goldfrank, NE Flomenhaum, NA Lewin, et al. Appleton and Lange, Norwalk 1990; 270–287
   Google Scholar
• Brimacombe JR, Scully M, Swainston R. Propranolol overdose—a dramatic response to calcium chloride. Med J Aust 1991; 155: 267–268
   PubMed Web of Science ®Google Scholar
• Bania TC, Sauter D, Hoffman RS. Management of hemodynamic compromise in the poisoned patient. Critical Care Toxicology, RS Hoffman, LR Goldfrank. Churchill Livingstone, New York 1991; 179–202
   Google Scholar
• Aruoma OI, Smith C, Cecchini R, Evans PJ, Halliwell B. Free radical scavenging and inhibition of lipid peroxidation by beta-blockers and by agents that interfere with calcium metabolism. Biochem Pharmacol 1991; 42: 735–743
   PubMed Web of Science ®Google Scholar
• Du Souich P, Caillé G, Larochelle P. Enhancement of nadolol elimination by activated charcoal and antibiotics. Clin Pharmacol Ther 1983; 33: 585–590
   PubMed Web of Science ®Google Scholar
• Kärkkäinen S, Neuvonen PJ. Effect of oral charcoal and urine pH on sotalol pharmacokinetics. Int J Clin Pharmacol Ther Toxicol 1984; 22: 441–446
   PubMedGoogle Scholar
• Soni N, Baines D, Pearson IY. Cardiovascular collapse and propranolol overdose. Med J Aust 1983; 2: 629–630
   PubMed Web of Science ®Google Scholar
• Branch RA, Shand DG, Nies AS. Increase in hepatic blood flow and d-propranolol clearance by glucagon in the monkey. J Pharmacol Exp Ther 1973; 187: 581–587
   PubMed Web of Science ®Google Scholar
• Benowitz N, Rowland M, Forsyth R, Melmon KL. Circulatory influences on lidocaine disposition. Clin Res 1973; 21: 467
   Google Scholar
• Lagerfelt J, Matell G. Attempted suicide with 5.1 g of propranolol, a case report. Acta Med Scand 1976; 199: 517–518
   PubMed Web of Science ®Google Scholar
• Vestal RE, Wood AJ, Shand DG. Reduced beta-adrenoceptor sensitivity in the elderly. Clin Pharmacol Ther 1979; 26: 181–186
   PubMed Web of Science ®Google Scholar
• Vincent JL, Leon M, Berre J, Melot C, Kahn RJ. Addition of enoximone to adrenergic agents in the management of severe heart failure. Crit Care Med 1992; 20: 1102–1106
   PubMed Web of Science ®Google Scholar
• Wetzel B, Hauel N. New cardiotonic agents—a promising approach for treatment of heart failure. Trends Pharmacol Sci 1988; 9: 166–170
   PubMed Web of Science ®Google Scholar
• Riou B, Barriot P, Rimailho M, Baud FJ. Treatment of severe chloroquine poisoning. N Eng J Med 1988; 318: 1–6
   PubMed Web of Science ®Google Scholar